-+ 0.00%
-+ 0.00%
-+ 0.00%

Cytokinetics CEO Robert I. Blum disposes of $526,800 in common shares

PUBT·08/31/2026 20:56:11
Listen to the news
Cytokinetics CEO Robert I. Blum disposes of $526,800 in common shares
  • Cytokinetics President and CEO Robert I. Blum exercised stock options for 7,500 shares on Aug. 31, 2026 at $10.6.
  • Blum sold 7,500 shares the same day at $70.24.
  • Directly held common stock fell to 377,820 shares.
  • Directly held non-qualified stock options declined to 164,245.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytokinetics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001061983-26-000089), on August 31, 2026, and is solely responsible for the information contained therein.